Company profile
Tandem Therapeutics company profile
Tandem Therapeutics develops peptide therapeutics that target and treat the extracellular matrix barrier.
Business identity
- Website
- https://tandem-tx.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Country code
- CH
- Continent
- Europe